National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

romiplostimPatient Information
A recombinant protein with megakaryopoiesis stimulating activity. Romiplostim mimics endogenous thrombopoietin (TPO), directly binding to and activating the platelet thrombopoietin receptor (TpoR, Mpl, or CD110 antigen), a cytokine receptor belonging to the hematopoietin receptor superfamily. Activation of TpoR stimulates the proliferation and differentiation of megakaryocytes, resulting in an increase in the production of blood platelets. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Amgen megakaryopoiesis protein 2
US brand name:Nplate
Code name:AMG 531
Chemical structure name:methionyl, 227 amino acid C-terminal immunoglobulin G1 (human Fc fragment) fusion protein with 41 amino acid peptide, dimer



Previous:Rodex, rofecoxib, Roferon-A, Roferon-A, romidepsin
Next:Romozin, ropivacaine hydrochloride, roquinimex, rosiglitazone maleate, Roxanol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov